Ocumension Therapeutics (HKSE:01477) Other Operating Expense : HK$156.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Other Operating Expense?

Ocumension Therapeutics's Other Operating Expense for the six months ended in Dec. 2023 was HK$76.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$156.3 Mil.

Ocumension Therapeutics's quarterly Other Operating Expense increased from Dec. 2022 (HK$77.5 Mil) to Jun. 2023 (HK$80.4 Mil) but then declined from Jun. 2023 (HK$80.4 Mil) to Dec. 2023 (HK$76.0 Mil).

Ocumension Therapeutics's annual Other Operating Expense increased from Dec. 2021 (HK$-0.5 Mil) to Dec. 2022 (HK$152.6 Mil) and increased from Dec. 2022 (HK$152.6 Mil) to Dec. 2023 (HK$156.3 Mil).

Ocumension Therapeutics Other Operating Expense Historical Data

The historical data trend for Ocumension Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Other Operating Expense Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-5.95

-0.47

152.59

156.34

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial						-0.47	78.79	77.53	80.36	75.97

Ocumension Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$156.3 Mil.

Ocumension Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (HKSE:01477) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (HKSE:01477) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

5DG:Germany

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (HKSE:01477) Headlines

No Headlines